Crossmark

Moving together to facilitate equity and inclusion in research. The co-production of interventions for clinical trials to facilitate participation of people from ethnically diverse communities

Crossref DOI link: https://doi.org/10.1186/s12961-025-01435-4

Published Online: 2026-01-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ramage, Emily R. https://orcid.org/0000-0002-0599-7028
Sharma, Hannah https://orcid.org/0009-0007-4365-6981
Batchelor, Frances

Bicknell, Erin https://orcid.org/0000-0002-8057-8712
Bongiovanni, Lyn

Brijnath, Bianca

Cahill, Priyanka https://orcid.org/0009-0006-9124-3623
Callisaya, Michele https://orcid.org/0000-0003-2122-1622
Chudecka, Agnieszka https://orcid.org/0009-0008-7857-5986
Cursio-Barcham, Rosa

Engel, Lidia

Klaic, Marlena

Lam, Eleanor

Lim, Wen Kwang

McDonald, Cassie E. https://orcid.org/0000-0001-9518-5869
Pinheiro, Marina B. https://orcid.org/0000-0001-7459-5105
Sherrington, Catherine https://orcid.org/0000-0001-8934-4368
Vogrin, Sara https://orcid.org/0000-0002-1597-9421
Zanker, Jesse https://orcid.org/0000-0003-3463-6827
Zheng, Cheng

Said, Catherine M. https://orcid.org/0000-0002-8773-9750
,
Funding

Funding for this research was provided by:

Medical Research Future Fund (MRF2015963)
License Information

Text and Data Mining valid from 2026-01-20

Version of Record valid from 2026-01-20
More Information

Article History

Received: 14 October 2024

Accepted: 26 November 2025

First Online: 20 January 2026

Declarations

:

: Ethics approval was received from the Royal Melbourne Hospital Human Research Ethics Committee (HREC/88727/MH-2022) and participants provided informed consent prior to participation.

: Not applicable.

: E.R. declares equity in Hydro Functional Pty Ltd. and has received Honoraria from Methinks, Moleac and a CIHR 2024 Catalyst Grant (no. SCT-191292).

Document is current

Any future updates will be listed below